0001104659-21-124273.txt : 20211007
0001104659-21-124273.hdr.sgml : 20211007
20211007185540
ACCESSION NUMBER: 0001104659-21-124273
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211006
FILED AS OF DATE: 20211007
DATE AS OF CHANGE: 20211007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dayno Jeffrey M.
CENTRAL INDEX KEY: 0001615993
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39450
FILM NUMBER: 211313423
MAIL ADDRESS:
STREET 1: 460 EAST SWEDESFORD ROAD
STREET 2: SUITE 1050
CITY: WAYNE
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc.
CENTRAL INDEX KEY: 0001802665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822279923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 630 W GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
BUSINESS PHONE: (484) 539-9800
MAIL ADDRESS:
STREET 1: 630 W GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
4
1
tm2129561-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-10-06
0
0001802665
Harmony Biosciences Holdings, Inc.
HRMY
0001615993
Dayno Jeffrey M.
630 W. GERMANTOWN PIKE, SUITE 215
PLYMOUTH MEETING,
PA
19462
0
1
0
0
Chief Medical Officer
Common Stock
2021-10-06
4
M
0
1800
8.22
A
1800
D
Common Stock
2021-10-06
4
S
0
1800
40.0992
D
0
D
Stock Option
8.22
2021-10-06
4
M
0
1800
0
D
2027-11-13
Common Stock
1800
71669
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.075 to $40.41. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option is currently vested with respect to 62,082 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on November 1, 2021.
/s/ Christian Ulrich, Attorney-in-fact
2021-10-07